Axa S.A. Buys 262,004 Shares of Doximity, Inc. (NASDAQ:DOCS)

AXA S.A. boosted its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 147.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 439,232 shares of the company's stock after purchasing an additional 262,004 shares during the period. AXA S.A. owned about 0.24% of Doximity worth $23,451,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Mercer Global Advisors Inc. ADV boosted its position in Doximity by 2.3% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,993 shares of the company's stock valued at $854,000 after buying an additional 360 shares in the last quarter. Freestone Grove Partners LP acquired a new position in shares of Doximity during the 4th quarter valued at $9,123,000. Kapitalo Investimentos Ltda acquired a new stake in shares of Doximity in the 4th quarter valued at about $50,000. Utah Retirement Systems increased its holdings in shares of Doximity by 3.1% during the fourth quarter. Utah Retirement Systems now owns 103,173 shares of the company's stock valued at $5,508,000 after acquiring an additional 3,143 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC bought a new position in shares of Doximity in the fourth quarter valued at $726,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. The trade was a 11.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 37.40% of the company's stock.

Doximity Trading Down 0.4 %

NASDAQ:DOCS traded down $0.25 during mid-day trading on Friday, reaching $59.10. The company's stock had a trading volume of 1,770,373 shares, compared to its average volume of 2,011,334. The stock has a market cap of $11.03 billion, a P/E ratio of 59.10, a PEG ratio of 4.10 and a beta of 1.41. The firm's fifty day moving average price is $58.16 and its two-hundred day moving average price is $57.03. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Raymond James reiterated an "outperform" rating and issued a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Mizuho increased their target price on shares of Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC lifted their price target on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Truist Financial cut their target price on shares of Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a report on Thursday, April 10th. Finally, KeyCorp dropped their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $65.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.